Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law The FDA just changed the rules on peptides effective April 15, 2026. BPC 157, GHK Cu, MOTS C, and TB 500 have been removed from the Category 2 restricted compounding list. Here is what clarifying the BPC 157 TB 500 FDA situation since it's getting garbled in basically every thread : r Biohackers Influencers are Lying About the FDA and Peptides This is the Truth (May 2026) The FDA didn't bring peptides back. It opened a formal docket. And that distinction matters. This is not a blanket approval. Not a wellness free for all. Not one announcement that changes everything overnight. Last week @fda sends out clarification on who can and cannot compound #glp1 like #tirzeaptide and #semaglutide and this week ProRx 503b shuts down GLP 1 compounding while @martymakary is photographed holding bootleg #